Phase 2
Who we are
INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer
Trial of Nivolumab With FOLFOX After Chemoradiation in Rectal Cancer Patients
The Drug Rediscovery Protocol (DRUP Trial)
The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy
A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors
Window of Opportunity Study in Colorectal Cancer
Dabrafenib + Trametinib + PDR001 In Colorectal Cancer
A Trial of Ipatasertib in Combination With Atezolizumab
Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
Chemoembolization (Lifepearls-Irinotecan) in Patients With Colorectal Cancer and Metastatic Disease
